Purchase Order HHSF223201510524A
Award Date 9/13/15
Potential Completion Date 10/13/15
Potential Value $110K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20903, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services Food and Drug Administration to Simulations Plus Inc., a prime contractor that specializes in drug discovery and development simulation and modeling software. The $130,000 contract is for the extension and validation of Simulations Plus' GastroPlus ocular compartmental absorption and transit model. There is no set-aside designation for this contract. Simulations Plus has received over $5 million in...
- This is a firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Simulations Plus Inc. for an annual software license for one user to access the company's ADMET and GastroPlus modeling and simulation software. The total ceiling value of the contract is $96,898.01 and the ultimate completion date is January 31, 2026. The software provided under this award supports pharmaceutical drug research, development, and regulatory assessment through...
- This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Simulations Plus Inc. for the renewal of ADMET Predictor software licenses and associated support services. The contract, valued at $100,337.38, has an ultimate completion date of February 19, 2026. The original solicitation sought to renew the FDA's existing licenses for the ADMET Predictor software, which is used by the Center for Tobacco Products (CTP) for toxicology data mining and assessing the...
- This is a $1,844,289.00 definitive cost-no-fee contract awarded by the Food and Drug Administration (FDA) to the University of Florida (UF) Division of Sponsored Research. The contract is for advancing in vitro and (patho)physiology-based pharmacokinetics models to understand and predict pulmonary absorption and tissue retention of inhaled drugs. The contract has no set-aside designation. As a subcontractor, Simulations Plus Inc. will provide modeling and simulation services to support the...
- The Food and Drug Administration awarded a firm fixed-price purchase order to Certara UK LIMITED (doing business as Certara) on September 6, 2023, for SIMCYP software licenses with a ceiling value of $815,948. The contract will be performed in Great Britain, United Kingdom, and is scheduled for ultimate completion by September 20, 2028. No set-aside designation was applied to this award. Certara provides physiologically-based pharmacokinetic (PBPK) modeling software that simulates drug...
- The Department of Health and Human Services, Food and Drug Administration awarded a fixed-price purchase order contract to Certara USA Inc., doing business as Tripos (De), for an annual Phoenix Quantum software subscription. The contract, with a potential value of $216,547.78, provides the FDA's Office of Clinical Pharmacology with the necessary modeling and simulation tools to analyze and verify sponsor submissions, including Investigational New Drug, New Drug, Biologics Licensing, and...
- This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Certara USA Inc., a leading provider of biosimulation software and consulting services. The contract, valued at $16,441.10, is for the procurement of software licenses for Certara's proprietary modeling and simulation tools, including Phoenix WinNonlin, Certara Phoenix, CHEMOFFICE, and SEND EXPLORER. These software products enable federal scientists and reviewers to conduct...
- This is a $169,504.71 firm-fixed price purchase order awarded by the U.S. Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Certara USA Inc., doing business as Tripos (DE), a technology-enabled drug development and drug safety consultancy. The contract provides annual named user server licenses for Certara's Phoenix WinNonlin, Phoenix Connect, Phoenix NLME software, as well as an unlimited server license for distributed computing. This supports the FDA's...
- This is a $165,457 firm-fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Global Life Sciences Solutions USA LLC, a for-profit limited liability company. The contract is for the delivery of mechanistic chromatography modeling software. This award is not associated with a set-aside program. Through this contract, the FDA is acquiring scientific software to support its biomedical research and laboratory operations. Global Life Sciences Solutions USA LLC is...
- This federal contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Certara USA Inc., doing business as Tripos (DE), is for $83,806.57 to provide Certara Phoenix software licenses for pharmacokinetic modeling and simulation. The contract is a firm fixed-price purchase order with a completion date of August 31, 2026. Certara is a technology-enabled drug development and drug safety consultancy that has received numerous prior federal contract...